This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignees: Boston University, The University of British Columbia. Active years: 2017.
Company Filing History:
1 out of 833 
1 out of 959 
Years Active: 2017
Title: The Innovative Contributions of Darryl Andrew Knight
Introduction
Darryl Andrew Knight, located in Vancouver, Canada, is a notable inventor recognized for his contributions to medical innovations. With a focus on treating respiratory diseases, Darryl has a patent that underscores his commitment to improving health outcomes for individuals suffering from emphysema and chronic obstructive pulmonary disease (COPD).
Latest Patents
Darryl holds a patent for a therapeutic agent designed specifically for the treatment of emphysema and COPD. This invention revolves around the use of a GHK tripeptide, offering novel methods for therapy. Additionally, his patent encompasses techniques for determining the state of the lungs through specific biomarkers, showcasing his dual focus on treatment and diagnosis.
Career Highlights
Throughout his career, Darryl has been associated with prestigious institutions, including Boston University and the University of British Columbia. His work in these respected environments has facilitated advancements in pulmonary health, melding research with practical applications that address significant medical challenges.
Collaborations
Darryl has collaborated with accomplished professionals in his field, including Avrum Spira and Marc Elliott Lenburg. These partnerships have likely enhanced the depth and effectiveness of his research, allowing for a multidisciplinary approach to tackling complex health issues, particularly within the realm of pulmonary disease.
Conclusion
In conclusion, Darryl Andrew Knight's contributions to medical innovation, particularly in the treatment of emphysema and COPD, exemplify the importance of inventors in advancing healthcare. His patent not only reflects his ingenuity but also stands as a testament to the collaborative efforts within academia that promote significant breakthroughs in medicine.